| Cat. No. |
Product Name |
Information |
| PC-23093 |
RTI-348
CB1 antagonist
|
RTI-348 is a potent, peripherally selective, orally active, and metabolically stable antagonist of cannabinoid receptor 1 (CB1) with Ki of 6.2 nM, 153-fold selective over CB2. |
| PC-22602 |
RNB-61
CB2R agonist
|
RNB-61 is a highly potent, selective and orally bioavailable cannabinoid CB2 receptor (CB2R) full agonist with Ki of 0.57/1.33 nM for hCB2R/mCB2R, >5000-fold selective over hCB1R. |
| PC-22545 |
TM38837
CB1 inverse agonist
|
TM38837 is a potent, selective peripheral cannabinoid receptor 1 (CB1) inverse agonist with IC50 of 24 nM, 200-fold selective over CB2 receptor. |
| PC-22234 |
HU-308
CB2 agonist
|
HU-308 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 22.7 nM in competition binding assay, does not bind to CB1 receptor. |
| PC-22233 |
HU-910
CB2 agonist
|
HU-910 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 6 nM in competition binding assay, IC50 of 162 nM in cAMP assay. |
| PC-22211 |
SCH225336
CB2 inverse agonist
|
SCH225336 (SCH336) is a potent, selective cannabinoid receptor CB2 inverse agonist with Ki of 0.4 nM, >2000-fold selective over CB1 receptor. |
| PC-22188 |
SR141716
CB1 antagonist
|
Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with Ki of 1.8 nM, no affinity for peripheral cannabinoid receptor. |
| PC-22167 |
AM10257
CB2 antagonist
|
AM10257 is a potent, selective cannabinoid receptor 2 (CB2) antagonist with IC50 of 47 nM. |
| PC-22115 |
SMM-189
CB2 inverse agonist
|
SMM-189 is a selective cannabinoid receptor 2 (CB2) inverse agonist with Ki of 121.3 nM, 40-fold selective over CB1 receptor. |
| PC-21983 |
BAY38-7271
CB1/CB2 agonist
|
BAY 38-7271 is selective, highly potent and cannabinoid CB1/CB2 receptor agonist with 0.46-1.85 nM for rat brain, human cortex, or recombinant human CB1 receptors. |
| PC-21521 |
AM4113
CB1 neutral antagonist
|
AM4113 is a high affinity, selective cannabinoid CB1 neutral antagonist with Ki of 0.89 nM, exhibits 100-fold selectivity over CB2 receptors. |
| PC-21463 |
AM6527
CB1 antagonist
|
AM6527 is a highly potent, selective cannabinoid CB1 receptor antagonist with binding Ki of 4.88 nM, 100-fold selective over CB2 receptors. |
